Loading...
Docoh

David Lebwohl

David Lebwohl is EVP, Chief Medical Officer of Intellia Therapeutics Inc.

Person profile

Roles
Intellia Therapeutics EVP, Chief Medical Officer
Address
Cambridge, Massachusetts
Employees
SEC CIK

Calendar

25 Jun 22
Date Company Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
1 Mar 22 NTLA Intellia Therapeutics Stock Option Common Stock Grant Acquire A No No 79.85 20,203 1.61M 20,203
1 Mar 22 NTLA Intellia Therapeutics Common Stock Grant Acquire A No No 0 13,816 0 24,738
1 Mar 22 NTLA Intellia Therapeutics Stock Option Common Stock Grant Acquire A No No 79.85 13,816 1.1M 13,816
1 Jan 22 NTLA Intellia Therapeutics Common Stock Sell Dispose S No No 112.24 1,051 117.96K 10,922
1 Jan 22 NTLA Intellia Therapeutics Common Stock Option exercise Acquire M No No 0 3,187 0 11,973
1 Jan 22 NTLA Intellia Therapeutics RSU Common Stock Option exercise Dispose M No No 0 3,187 0 9,563
5 Nov 21 NTLA Intellia Therapeutics Common Stock Sell Dispose S No Yes 135.34 200 27.07K 8,714
5 Nov 21 NTLA Intellia Therapeutics Common Stock Sell Dispose S No Yes 134.07 548 73.47K 8,914
5 Nov 21 NTLA Intellia Therapeutics Common Stock Sell Dispose S No Yes 132.62 452 59.94K 9,462
5 Nov 21 NTLA Intellia Therapeutics Common Stock Sell Dispose S No Yes 131.71 1,200 158.05K 9,914
Financial reports
No filings
Current reports
No filings
Registration and prospectus
No filings
Proxies
No filings
Other
No filings